Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016
Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Effect of Vitamin C and vitamin E on Lung Contusion: acohort,prospective Randomized Clinical Trial study Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018
Treatment of sarcoidosis – pentoxifylline Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019
Evaluation of vitamin D in bronchial asthma and the effect of vitamin D supplementation on asthma severity and control: A randomised control trial Source: International Congress 2014 – Asthma: clinical problems Year: 2014
Combination of pentoxifylline and steroids in sarcoidosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005
Comparative assessment of umeclidinium/vilanterol (UMEC/VI) combination therapy among symptomatic COPD patients Source: International Congress 2014 – Asthma and COPD management Year: 2014
Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014
Idiopathic pulmonary fibrosis treatment: Combined pirfenidone + acetylcysteine vs N-acetylcysteine in monotherapy Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014
Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Vitamin D concentration and patient reported outcomes in sarcoidosis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015
Effect of inhaled beclomethasone or placebo on brain stem activity in a patient chronically treated with steroids - Preliminary report Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016